Based on the role of AKT in DSB repair discussed above and the common disruption of the RTK/PI3K/AKT pathway in human cancers, e.g., the hyperactivation of AKT in over 50% of human tumors, AKT is a suitable target in combination with radiotherapy. The gene discussed is PIK3CA; the disease is cancer.